Avenue therapeutics to present at sidoti january micro-cap investor conference

Miami, jan. 11, 2024 (globe newswire) -- avenue therapeutics, inc. (nasdaq: atxi) (“avenue” or the “company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced that alexandra maclean, m.d., chief executive officer, will present a corporate update at the sidoti january micro-cap investor conference on thursday, january 18, 2024 at 10:00 a.m. est.
ATXI Ratings Summary
ATXI Quant Ranking